Ioana Baldea
Overview
Explore the profile of Ioana Baldea including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
609
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ribeiro A, Pereira-Leite C, Rosado C, Aruci E, Colley H, Kortekaas Krohn I, et al.
JID Innov
. 2025 Feb;
5(2):100340.
PMID: 39925780
Skin acts as a dynamic interface with the environment. Pathological alterations in the skin barrier are associated with skin diseases. These conditions are characterized by specific impairments in epidermal barrier...
2.
Baldea I, Soran M, Stegarescu A, Opris O, Kacso I, Tripon S, et al.
Gels
. 2025 Jan;
11(1).
PMID: 39851993
Chronic wounds are a major health problem, affecting millions of people worldwide. Resistance to treatment is frequently observed, requiring an extension of the wound healing time, and improper care can...
3.
Mormile C, Opris O, Bellucci S, Lung I, Kacso I, Turza A, et al.
Gels
. 2025 Jan;
11(1).
PMID: 39851987
In this study, alginate-based composite beads were developed for the delivery of resveratrol, a compound with therapeutic potential. Two formulations were prepared: one with sodium alginate and resveratrol (AR) and...
4.
Toma C, Popa R, Ciobanu L, Baldea I, Amorim I, Bochynska D, et al.
BMC Vet Res
. 2025 Jan;
21(1):29.
PMID: 39833798
Background: Ovine pulmonary adenocarcinoma (OPA) is caused by Jaagsiekte sheep retrovirus (JSRV) and is considered an important potential animal model for human lung cancer. The precise mechanisms of OPA oncogenesis...
5.
Ielciu I, Filip G, Sevastre-Berghian A, Baldea I, Olah N, Burtescu R, et al.
Nutrients
. 2025 Jan;
17(1.
PMID: 39796593
Background/aim: L. () is an aromatic medicinal species with important nutraceutical potential, having rosmarinic acid (RA) as one of its main metabolites. The present study aims to evaluate the effects...
6.
Baldea I, Moldovan R, Nagy A, Bolfa P, Decea R, Miclaus M, et al.
Int J Mol Sci
. 2025 Jan;
25(24.
PMID: 39769112
Development of cocrystals through crystal engineering is a viable strategy to formulate poorly water-soluble active pharmaceutical ingredients as stable crystalline solid forms with enhanced bioavailability. This study presents a controlled...
7.
Vulcan T, Suciu T, Lenghel L, Toma V, Decea N, Moldovan R, et al.
Med Pharm Rep
. 2024 Nov;
97(4):516-527.
PMID: 39502756
Background: Polycystic ovary syndrome (PCOS) is commonly associated with obesity and may be exacerbated by the lack of vitamin D3. Aim: The study aimed to investigate the effects of vitamin...
8.
Dulf P, Coada C, Florea A, Moldovan R, Baldea I, Dulf D, et al.
Nanomaterials (Basel)
. 2024 Oct;
14(20).
PMID: 39452984
Gold nanoparticles (Au-NPs) have been explored as potential vectors for enhancing the antitumor efficacy of doxorubicin (DOX) while minimizing its cardiotoxic effects. However, the impacts of DOX Au-NPs on cardiac...
9.
Dulf P, Coada C, Florea A, Moldovan R, Baldea I, Dulf D, et al.
Antioxidants (Basel)
. 2024 Sep;
13(9).
PMID: 39334727
Doxorubicin (DOX) is an effective anticancer drug, but its use is limited by dose-dependent heart toxicity. Quercetin is a natural antioxidant frequently studied for its beneficial properties. Moreover, a wide...
10.
Florea C, Rosu R, Moldovan R, Vlase L, Toma V, Decea N, et al.
Food Chem Toxicol
. 2024 Jan;
184:114429.
PMID: 38176578
TMAO, a gut microbiota derived byproduct, has been associated with various cardiometabolic diseases by promoting oxidative stress and inflammation. The liver is the main organ for TMAO production and chronic...